XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Find ways to quickly earn actual cash with various methods that fit your lifestyle. Start maximizing your income today.
23,852 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Three stocks in an overlooked sector are gaining attention in 2026 as AI and data-center demand drive automation and ...
Terawulf reports a Q4 revenue miss while its high-performance computing leases rise, signaling a strategic pivot towa...
Bitcoin has slid about 40% from its recent high, sparking questions about whether investors should buy the dip. This ...
Hasbro rides a digital IP pivot to stronger earnings, while Whirlpool grapples with tariffs and margin pressure. Inve...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
When markets slump, two crypto giants throw up different signals. This guide breaks down the case for Bitcoin as the ...
A veteran market observer argues that timing the market is a losing bet. New data shows the cost of waiting and the b...
Coinbase expands its collateral options by adding SOL to its crypto-backed loan program, unlocking new borrowing powe...
Oil prices push higher as supply fears mount, triggering a broad debt selloff and jittery stock futures. Iran tension...